Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Work In Process (2024 - 2025)

Historic Work In Process for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to $6.0 million.

  • Day One Biopharmaceuticals' Work In Process changed N/A to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' Work In Process stood at $6.0 million.
  • In the past 5 years, Day One Biopharmaceuticals' Work In Process ranged from a high of $6.0 million in Q3 2025 and a low of $2.4 million during Q4 2024